Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating subcutaneous amlitelimab as monotherapy versus placebo in adults with severe Alopecia Areata, and the trial is currently ACTIVE_NO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Amlitelimab (amlitelimab)

Snippet

Sponsor: Sanofi | Conditions: Alopecia Areata | Phase 2 | Status: ACTIVE_NOT_RECRUITING